Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cetaphil Eczema Restoraderm Soothing Moisturizer is an over-the-counter (OTC) topical skin protectant and moisturizer developed by Galderma for the management of eczema-prone skin. The product contains 1% colloidal oatmeal as its active ingredient to relieve minor skin irritation and itching. It is formulated with proprietary Ad-Resyl to help restore the skin barrier and support a healthy microbiome, along with filaggrin technology to lock in hydration and strengthen the skin's natural defenses. Clinically shown to provide 48-hour hydration, the formulation is free of parabens, fragrances, and steroids, and is accepted by the National Eczema Association.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cetaphil Eczema Restoraderm Soothing Moisturizer.